Biohaven Ltd. (BHVN)
15.30
+0.82
(+5.66%)
USD |
NYSE |
Nov 09, 12:07
Biohaven EPS Diluted (Quarterly) : -0.8559 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.8559 |
| June 30, 2026 | -0.9115 |
| March 31, 2026 | -0.8843 |
| December 31, 2025 | -1.211 |
| September 30, 2025 | -1.639 |
| June 30, 2025 | -1.936 |
| March 31, 2025 | -2.174 |
| December 31, 2024 | -1.849 |
| September 30, 2024 | -1.699 |
| June 30, 2024 | -3.643 |
| Date | Value |
|---|---|
| March 31, 2024 | -2.200 |
| December 31, 2023 | -1.811 |
| September 30, 2023 | -1.501 |
| June 30, 2023 | -1.324 |
| March 31, 2023 | -1.034 |
| December 31, 2022 | -2.949 |
| September 30, 2022 | -1.010 |
| June 30, 2022 | -3.158 |
| March 31, 2022 | -1.424 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0017 |
| Brainstorm Cell Therapeutics, Inc. | -0.3494 |
| Summit Therapeutics, Inc. | -0.2611 |
| Kezar Life Sciences, Inc. | -0.7838 |
| Protara Therapeutics, Inc. | -0.3451 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -129.28M |
| Total Expenses (Quarterly) | 129.28M |
| Enterprise Value | 2.326B |
| Earnings Yield | -25.25% |
| Normalized Earnings Yield | -24.63 |